Abbott Laboratories revealed on Wednesday that its net sales in the second quarter reached $11.3 billion.

The company's earnings per share surpassed analyst expectations to land at $1.43

Furthermore, Abbott Labs significantly went above expert estimations regarding COVID-19-related sales, hitting $2.3 billion in Q2.